NRX Pharmaceuticals (NRXP) Return on Sales [ROS] (2017 - 2026)
NRX Pharmaceuticals (NRXP) recorded Return on Sales [ROS] of -590.83% in Q2 2026, down 159.74 percentage points from the prior quarter.
Powered by 
Analysis
NRX Pharmaceuticals (NRXP) Return on Sales [ROS] (2017 - 2026) Analysis & Trends
On a TTM basis, NRX Pharmaceuticals' Return on Sales [ROS] came in at -580.71% as of Jun 30, 2026; for FY2025, it came in at -1324.41%.
- Quarterly Return on Sales [ROS] has ranged from -1662.81% in Q3 2025 to -431.09% in Q1 2026 over the past five years.
- Per Business Quant, the preceding three quarters came in at -431.09% (Q1 2026), -470.40% (Q4 2025) and -1662.81% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 28.37% |
| 10 | NRX Pharmaceuticals | 107.46 Mn | 59.05 Mn | 426,000.00 | -590.83% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -590.83% |
| Mar 31, 2026 | -431.09% |
| Dec 31, 2025 | -470.40% |
| Sep 30, 2025 | -1,662.81% |
| Mar 31, 2025 | -18,580,681.82% |
| Dec 31, 2024 | -9,297,487.44% |
| Sep 30, 2024 | -2,701,319.26% |
| Mar 31, 2021 | -29,096,590.91% |
| Dec 31, 2020 | -40,651,024.32% |
| Sep 30, 2020 | -921,144.72% |
| Jun 30, 2020 | 418.99% |
| Mar 31, 2020 | -105.50% |
| Dec 31, 2019 | -110.84% |
| Sep 30, 2019 | -70.98% |
| Jun 30, 2019 | -44.78% |
| Mar 31, 2019 | -42.62% |
| Sep 30, 2018 | -77.72% |
| Jun 30, 2018 | -99.75% |
| Mar 31, 2018 | -90.08% |
| Dec 31, 2017 | -393.40% |
API Access
NRX Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=NRXP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "NRXP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=NRXP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();